A round of Series A financing brought in approximately $16.8 million for Spanish preclinical stage medical device maker Anaconda Biomed. The proceeds will be used for advancing development of the company's third-generation stented aspiration thrombectomy system, ANCD BRAIN, for treating acute ischemic stroke.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.